MicroRNA-301 mediates proliferation and invasion in human breast cancer. - Wikidata - awgldk - TriplyDB

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

http://www.wikidata.org/entity/Q34169881

about

Tamoxifen Resistance: Emerging Molecular Targets Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype Roles for miRNAs in endocrine resistance in breast cancer Focus on PTEN Regulation Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes Decoding the usefulness of non-coding RNAs as breast cancer markers Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN Downregulation of eIF4G by microRNA-503 enhances drug sensitivity of MCF-7/ADR cells through suppressing the expression of ABC transport proteins.Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7.MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases Genetic variation in hippocampal microRNA expression differences in C57BL/6 J X DBA/2 J (BXD) recombinant inbred mouse strains MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R.Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor.Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer MicroRNA301 is a potential diagnostic biomarker for hepatocellular cancer.DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells.miRNAs and estrogen action.MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4 Epigenetic mechanisms in commonly occurring cancers.MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3)MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation.Endocrine resistance in breast cancer: from cellular signaling pathways to epigenetic mechanisms.Modulation of tumorigenesis by the pro-inflammatory microRNA miR-301a in mouse models of lung cancer and colorectal cancer Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301

P2860

Q26739969-CA95DC35-B14E-4872-A735-CE891F5D2D39 Q26776113-CE795098-CAFC-49FF-A71F-2D2A1A33947F Q26783076-EED258B6-F652-4077-8863-4523C79C2261 Q26797287-B31209C7-B2A7-4CC1-8D12-4109CF6C6589 Q28025433-080FDBEE-DD41-419E-ADF1-ADD7F8F0B1E9 Q28069370-885FE0A8-78CF-4452-9789-CAFBFEDB3909 Q28302352-6D1A48C0-86E0-4613-AB57-E4ED565EB03D Q33599465-5AF7B771-685E-405D-845C-7119B23438F9 Q33623176-9F817B19-6F21-4551-9CCF-270E46681143 Q33751074-C3B0BE4D-4667-4899-8789-C95CBCBA00CF Q34283082-7833F3FE-493D-4932-A453-47978E173E79 Q34297723-3AED7AFE-F1A1-41C4-86A2-2C955FE19222 Q34326881-140550EC-3B1B-4CE3-BC22-5D258A5FF65F Q34391443-2333A1D8-766C-499F-BA2F-81523F9A1354 Q34413899-BA5F38AF-B8D7-4362-8C44-CBE458245E67 Q34442762-AFE75B26-185D-4C58-9A72-7FA3FE9F79DF Q34491120-F9D25510-5B25-4EA6-9F45-8CC69814170F Q34576641-7BC0D273-9B1B-4EB2-963E-2FA483DBC2E1 Q34689061-6BB16CB3-E1FC-45C7-9AB7-C7FF1A049068 Q34733033-FD84CF93-DF53-4D6D-8128-74306DD22423 Q34814749-8EBEE3CE-8ECF-4F6E-8E5D-3F5A69E9BC66 Q34987026-34B05111-F277-4DAB-82BB-A5056F06C7C0 Q35005275-C18F6510-ABD6-4F6C-B751-82DF0362E6B7 Q35128098-6A20321B-9017-4673-9664-D20EF776FB46 Q35180874-C7E716FC-31BA-4816-B820-A944E9DCE1E9 Q35854289-CD8A6497-F56D-447A-8176-99E76CAE1CC2 Q35905370-D442984A-E6C6-4E6A-865C-34475D615A81 Q35946984-B16A69A3-CF9F-4CAE-93B5-171DE16024F3 Q35974243-ED75BB6A-684D-4F13-81A4-4EB7520BB695 Q36275017-A1F6C61B-0213-4424-B2A3-F3531F4BA795 Q36286662-FD87E435-6401-4C4B-8BF7-1390FD9AF972 Q36356232-E65FDC0C-5FFD-4622-A559-1613AC007870 Q36370996-346DC619-7430-4F33-B5E3-1E6CE7BE3436 Q36589865-BF8D99B9-A507-4818-9301-BF2ED79F55FA Q36596220-E75C147C-968B-4F65-99DF-20ADDC25B0DE Q36727107-2E4E55C0-E8F2-42FA-A268-415F00170C7E Q36732439-BFCEF1E8-C869-4F95-98B3-C3D1444DB2D0 Q36846329-555BB30C-A106-46E3-86F5-702B4161AFC9 Q36882759-FF180C81-B686-4FD8-8BF2-C1B1E168F2E8 Q36955672-A6ED2C62-63A2-4BFA-AC8C-9247CCE9F0DB

P2860

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

http://www.wikidata.org/entity/Q34169881

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@ast

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@en

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@nl

type

label

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@ast

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@en

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@nl

prefLabel

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@ast

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@en

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

@nl

P1433

Q34169881-E95BB6BF-D064-4428-B24A-49D604F0F309

P1476

Q34169881-E02F38C0-4606-4AFE-A264-71C3DF84B669

P2093

Q34169881-0C012A6D-FAFC-403E-95EE-5C565772BF8A

Q34169881-3F70FA06-CAB3-4658-B849-A847E8C2AB85

Q34169881-440F9639-89EA-44C8-90A4-AC1531BCC820

Q34169881-558C490D-9C60-483E-A2BA-F0C9A25B8FB5

Q34169881-828B716F-DA2F-418D-9F00-6F0883DD0F9A

Q34169881-88E4EE4F-0910-4EC0-900E-F35029A06854

Q34169881-9A17719C-F772-4DA5-B729-DF26EAD34A31

Q34169881-A8B5FD6D-ADB5-4AF3-8E13-7B216A77577F

Q34169881-C32C80A9-16DA-420F-8A91-02E8C3760D75

P304

Q34169881-B8C47307-3693-4DCB-B1CB-088D3FFBC942

P31

Q34169881-9EBB0331-E39A-4441-9072-BD64A7A22B47

P356

Q34169881-EC437794-B8DD-461A-A301-7BF98DD45B00

P407

Q34169881-1342C57E-3C25-4677-8CD3-72BF936E7C71

P433

Q34169881-6B77A8E0-8025-4469-981A-D5AEF356A4A2

P478

Q34169881-3B3177F0-0FD8-422B-8352-3FB5914E82E6

P50

Q34169881-0230397D-560F-46BD-9BAE-29F7688FF4E3

Q34169881-1876E486-3D4D-4FA5-B24C-BC2D44FBE9B8

Q34169881-77AD3D14-7834-4D14-9364-BF969A467359

Q34169881-83DCC2D1-7E62-4622-80C9-9068BBE62415

P577

Q34169881-27DEA86E-67AF-44A9-A28E-1B4EC652FD9B

P5875

Q34169881-BE13D40F-D454-4400-BBEB-C8FF827A3F0D

P698

Q34169881-C96924C9-47BA-43DD-A5EE-3FF2AA825DCF

P921

Q34169881-4D34E55F-857C-4FDF-BF40-41612BAA06EB

P356

0008-5472.CAN-10-3369

P1433

Cancer Research

P1476

MicroRNA-301 mediates proliferation and invasion in human breast cancer

@en

P2093

Angela B Hui

http://www.w3.org/2001/XMLSchema#string

Christine P'ng

http://www.w3.org/2001/XMLSchema#string

David McCready

http://www.w3.org/2001/XMLSchema#string

Jasmine Tsang

http://www.w3.org/2001/XMLSchema#string

Jenna Sykes

http://www.w3.org/2001/XMLSchema#string

Kate Gerster

http://www.w3.org/2001/XMLSchema#string

Melania Pintilie

http://www.w3.org/2001/XMLSchema#string

Naomi Miller

http://www.w3.org/2001/XMLSchema#string

Wei Shi

http://www.w3.org/2001/XMLSchema#string

P304

2926-2937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-3369

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50363876

http://www.w3.org/2001/XMLSchema#string

P698

21393507

http://www.w3.org/2001/XMLSchema#string

P921